List studies with an onsite trial having woman orgasm from a remote controlled device atached to their clitoris?
Executive summary
Clinical research has tested clitoral stimulation devices and genital vibratory devices in onsite trials and reported increased lubrication, sensation and higher self‑reported orgasm rates among participants, but most peer‑reviewed trials evaluated medical clitoral therapy devices (vacuum or vibratory) rather than consumer app‑ or remote‑controlled sex toys [1] [2] [3] [4]. The literature supplied names several clinical studies with onsite testing that measured orgasm as an outcome, while consumer remote‑control vibrator reviews and product testing occupy a separate evidence stream without peer‑reviewed clinical trials in the provided sources [5] [6] [7].
1. What types of devices have been studied in onsite clinical trials
Historically, the clinical trials identified used two broad device classes in onsite therapeutic settings: clitoral suction (vacuum) therapy devices such as the EROS Clitoral Therapy Device (CTD), and handheld or external genital vibratory stimulation devices; both classes were applied in clinical or trial visits and measured sexual function domains including orgasm [1] [2] [3] [4].
2. Key single‑arm and prospective studies reporting orgasm outcomes
A single‑arm, prospective study of a genital vibratory stimulation device reported that at three months participants perceived increased vaginal lubrication, orgasm and genital sensation — with 65.0% reporting improved orgasm and 82.5% reporting improved genital sensation — after device therapy for arousal and orgasmic disorders [2]. Earlier clinical work testing an external vacuum‑type clitoral device (the EROS‑CTD) found improved ability to achieve orgasm, increased sensation and lubrication in women with arousal disorder compared with baseline controls in the small trials reported [1].
3. Randomized evidence in a targeted clinical population (FGM)
A randomized controlled trial evaluated a clitoral therapy device specifically for women affected by female genital mutilation and found the device’s suction‑based mechanism increased blood flow, engorgement and—by reported measures—facilitated reaching orgasm and improved related sexual function metrics; the paper characterizes the EROS‑CTD as FDA‑certified for promoting female sexual function by improving orgasm quality [3].
4. Pilot work in oncology patients showing orgasm domain improvements
A pilot study of irradiated cervical cancer patients using a battery‑powered clitoral vacuum device four times weekly for three months observed statistically significant improvements across Female Sexual Function Index domains, including orgasm, with median FSFI scores rising substantially from baseline to three months [4].
5. What the sources do not support — the gap about “remote‑controlled” consumer toys
The provided consumer and review sources document numerous app‑ and remote‑controlled vibrators that can produce hands‑free clitoral orgasms in private testing and user reviews (examples: Lovense Ferri, Lush models, Ferri panty vibrators), but these are product reviews and user testing rather than onsite clinical trials published in peer‑reviewed journals within the supplied reporting; the supplied clinical literature focuses on therapeutic vacuum and vibratory devices used in trials rather than commercially marketed remote‑control sex toys [5] [6] [7] [8].
6. Conclusion and reporting limits
In sum, onsite clinical trials that explicitly measured orgasm as an outcome exist for clitoral vacuum (EROS‑CTD) and genital vibratory stimulation devices and report meaningful improvements in orgasm frequency, lubrication and sexual satisfaction in selected populations [1] [2] [3] [4], whereas the evidence for app‑ or Bluetooth‑controlled consumer remote vibrators comes from product testing and reviews rather than the peer‑reviewed onsite clinical trials cataloged in the provided sources [5] [6] [7]. If the precise criterion is "onsite trial demonstrating women reaching orgasm from a remote‑controlled device attached to the clitoris," the supplied clinical studies demonstrate orgasm improvements for clinical vacuum and vibratory devices but do not supply a peer‑reviewed onsite trial explicitly testing commercially marketed remote‑control consumer clitoral vibrators under clinical trial conditions in the provided reporting [1] [2] [3] [4] [5].